Structures by: Richardson P. R.
Total: 7
C51H31F18Gd1O9P2
C51H31F18Gd1O9P2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 37 13537-13545
a=24.6540(8)Å b=22.2370(7)Å c=39.1070(12)Å
α=90° β=90° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.8887(8)Å b=4.9700(3)Å c=20.9607(19)Å
α=90° β=91.546(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.7925(11)Å b=4.9356(5)Å c=20.415(5)Å
α=90° β=92.266(14)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.5438(6)Å b=4.8464(3)Å c=19.203(3)Å
α=90° β=93.648(7)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.3706(7)Å b=4.7918(3)Å c=18.398(3)Å
α=90° β=94.078(8)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=3.8938(4)Å b=5.5612(6)Å c=28.566(8)Å
α=90° β=90° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.2791(7)Å b=4.7643(3)Å c=17.9649(17)Å
α=90° β=93.960(4)° γ=90°